CX Institutional Decreases Position in Cigna Group $CI

Key Points

• CX Institutional cut its Cigna Group position by 67.3% in the third quarter, selling 22,769 shares and retaining 11,062 shares valued at approximately $3.0 million. Institutional investors collectively own 86.99% of the company.
• Cigna reported quarterly earnings of $7.78 per share, exceeding estimates of $7.60, while revenue rose 6.7% year over year to $71.56 billion. The company also pays a quarterly dividend of $1.56, representing a 2.3% yield.
• Analyst sentiment remains broadly positive, with a consensus rating of “Moderate Buy” and an average price target of $338.24, versus a recent share price of $270.92. However, insiders sold 22,730 shares worth about $6.3 million over the past three months.

CX Institutional decreased its holdings in shares of Cigna Group (NYSE:CI - Free Report) by 67.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,062 shares of the health services provider's stock after selling 22,769 shares during the quarter. CX Institutional's holdings in Cigna Group were worth $3,007,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of CI. Assetmark Inc. boosted its position in shares of Cigna Group by 10.0% in the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider's stock valued at $17,515,000 after acquiring an additional 5,963 shares during the period. Mystic Asset Management Inc. bought a new stake in Cigna Group during the 2nd quarter worth approximately $2,808,000. KBC Group NV lifted its stake in Cigna Group by 6.4% in the 2nd quarter. KBC Group NV now owns 380,034 shares of the health services provider's stock worth $104,768,000 after purchasing an additional 22,978 shares in the last quarter. Sanctuary Advisors LLC bought a new position in shares of Cigna Group in the second quarter worth $11,043,000. Finally, Nykredit A S bought a new position in shares of Cigna Group in the second quarter worth $15,300,000. Institutional investors and hedge funds own 86.99% of the company's stock.

Cigna Group Price Performance

Shares of NYSE CI opened at $270.92 on Friday. The company has a 50 day moving average of $278.79 and a 200 day moving average of $280.50. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The firm has a market cap of $71.59 billion, a P/E ratio of 11.21, a PEG ratio of 0.90 and a beta of 0.29. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts' consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm had revenue of $71.56 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same quarter in the prior year, the company posted $7.20 earnings per share. The business's quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts expect that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th were given a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date was Tuesday, September 8th. Cigna Group's payout ratio is currently 25.82%.

Insider Buying and Selling

In related news, insider Nicole Jones sold 19,436 shares of the firm's stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares of the company's stock, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the transaction, the insider owned 5,053 shares of the company's stock, valued at $1,435,304.65. This trade represents a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 22,730 shares of company stock valued at $6,293,359. 0.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research firms recently issued reports on CI. Piper Sandler set a $370.00 price objective on Cigna Group and gave the company an "overweight" rating in a research note on Friday. Mizuho upped their target price on Cigna Group from $330.00 to $340.00 and gave the stock an "outperform" rating in a research note on Monday, June 8th. UBS Group reissued a "buy" rating on shares of Cigna Group in a report on Thursday. Jefferies Financial Group cut shares of Cigna Group from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Finally, Barclays boosted their price target on shares of Cigna Group from $304.00 to $310.00 and gave the stock an "equal weight" rating in a research note on Friday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $338.24.

Cigna Group Company Profile

The Cigna Group NYSE: CI is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.